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ABSTRACT 
 
CLINICAL STUDY OF FISTULA IN ANO – ANALYSIS OF 
VARIOUS SURGICAL MODALITIES IN PSG HOSPITALS,                  
A RETROSPECTIVE AND PROSPECTIVE STUDY 
INTRODUCTION: 
Fistula is an abnormal communication lined by granulation tissue between 
anal canal and skin, which causes chronic inflammatory process. It occurs 
secondary to infection of anal gland. It develops in 26-38% of patients following 
anal abscess. Incidence in men 12.3/1lakh population and in women 5.6/1lakh 
population. Surgery is the treatment for fistula in ano. Fecal incontinence, 
recurrence, persistent discharge can occur following surgery. Hence sphincter 
saving surgery (LIFT, VAAFT) practiced now a days. It is necessary to select ideal 
surgical procedure for fistula and continuous follow up of patient becomes 
mandatory. 
AIMS AND OBJECTIVES: 
My study is both retrospective and prospective analysis of patients who 
underwent fistula surgery in PSG hospital. Main objective is to identify 
1. Incidence in male and female 
2. Etiology 
3. Symptoms 
4. Various surgical techniques 
5. Complications 
6. Follow up 
The aim of my study includes 
 A retrospective and prospective analysis of various surgical treatment 
modalities in PSG hospitals on fistula in ano 
 To analyse the morbidity in patients fulfilling the inclusion / exclusion 
criteria, from admission till 6 months post operatively 
 To review the pathophysiology of anal fistula 
 To review both simple and complex fistulas and treatment options 
 To compare and analyse the efficacy and outcomes of all surgical 
treatment options 
METHODOLOGY: 
Type of study : retrospective and prospective study 
Period of study: jan 2014 to june 2015 
Place of study: PSG IMSR, Coimbatore 
Sample size: 75 cases 
 Plan of study:  
 The detailed case history, clinical examination, type of surgery, duration of 
study, complications of cases recorded. 
The following factors were compared for newer and older surgical 
techniques: 
 Anaesthesia, technique and operative care 
 Duration of surgery 
 Intra operative complications 
 Post operative complications – pain, discharge, bleeding, faecal incontinence 
 Length of hospital stay 
 Cost effectiveness 
 Post op readmissions 
 Recurrence 
INCLUSION CRITERIA 
- All types of fistulas – both high and low 
- Both male and female patients 
 
 EXCLUSION CRITERIA 
- Medical and surgical contraindications to spinal anaesthesia 
- Severe comorbidities 
- Superficial fistula 
- Complex fistula due to the following causes – inflammatory bowel disease, 
previous radiation therapy, TB, steroids, HIV 
- Diverticulitis 
OBSERVATION: 
In my study, 75 cases that were operated, 80% cases were simple and 20% 
cases were complex fistulas. Around 80% of patients belong to age group 30 – 50 
years of age. Fistulectomy and fistulotomy performed more. Newer modalities like 
LIFT, VAAFT also performed in my institution.  Intersphincteric fistula being the 
most common fistula operated which constitutes about 46%. Post operative period 
patients had complaints like pain, discharge, fever, bleeding, fecal incontinence, 
itching at wound site, constipation. Most commonest complaint being pain at the 
operated site. Patients also had comorbidities like diabetes, hypertension etc. which 
were also noted. Mean stay of patients in hospital around 4-6 days. Recurrence 
occurred in 5 cases which constitutes about 7%. Recurrence encountered in 2 
fistulectomy cases, 2 fistulotomy cases, 1 LIFT procedure. Mean period of 
recurrence is 3 months following surgery. 
CONCLUSION: 
Fistula in ano is one of the commonest problem encountered. Surgery is the 
treatment of choice. Patient may have recurrence, fecal incontinence following 
surgery. Hence proper assessment, appropriate surgical procedure and regular 
follow up of patients become mandatory    
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INTRODUCTION 
„Fistula‟ is the latin word for a reed, pipe or flute. Fistula in ano is an 
abnormal communication, lined by granulation tissue between the anal 
canal and the skin, which causes chronic inflammatory response. Most 
commonly these fistulae develop following an anal abscesses secondary  to 
infection of an anal gland. It is the most common cause of seropurulent 
discharge in perianal region. 
Anal fistulae originate from anal glands, which are located in the 
subepithelial layer of anal canal at the level of dentate line.The duct of 
each gland has a direct opening into anal crypt (Morgagni‟s crypt). Since 
the internal anal sphincter is a competent barrier against bacterial 
contamination, chronic infection of the anal gland can lead to a perianal 
abscess or fistula when it extends into intersphincteric plane. If the outlet 
of the glands blocked secondary to fecal material,foreign bodies or 
trauma,may results in stasis and infection and abscess can form which can 
eventually point to skin surface. The tract formed by this process is the 
fistula. Abscess can recur if fistula seals over resulting in accumulation of 
pus. It then comes to surface and the process is recurred again. 
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Anal fistulae alone do not cause any problem,it can be painful or irritating 
due to the pus draining through it. There is also possibility of formed stools 
passing through the fistula. Recurrent abscess results in morbidity like 
pain, it may be source of spread of infection. 
Surgery for fistula in ano is considered essential for decompression of 
acute abscesses and to prevent spread of infection. Now adays, fistula 
surgery is done as an elective procedure due to patients discomfort, 
problems associated with it. Fistula may present with pain, 
discharge,(either bloody or purulent),pruritis ani(itching sensation in 
perianal region),bleeding PR, diarrhea, skin excoriation,systemic 
manifestation if the abscess become infected. Some patients may present 
with active infection which often requires antibiotic treatment and clearing 
up, before definitive treatment. 
Fistula may be associated with the following diseases like inflammatory 
bowel disease, diverticulitis, tuberculosis, HIV infection, previous 
radiation exposure or steroid therapy. These patients may present with 
abdominal pain, weight loss, change in bowel habits. Hence associated 
diseases should be investigated and ruled out before doing definitive 
treatment for fistula in ano.  
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Antibiotics alone wont provide cure for fistula. It often needs a definitive 
procedures for complete cure. So definitive surgical treatments are done 
now adays.   
Treating anal fistula is a complex task because of anatomical location of 
disease,recurrence rate, potential risk of septic complications and post 
operative faecal incontinence. Main objective of surgery is to heal the 
fistula and minimize the morbidity of disease. Many surgical techniques 
including fistulectomy, fistulotomy, seton technique, endorectal 
advancement flap, LIFT, VAAFT, fibringlue and fibrinplug used for 
treatment of fistula. Eradication of sepsis and maintainence of continence 
are two great challenges for the success of surgery. Hence ideal decision 
should be made to choose appropriate surgical technique for treatment of 
fistula in ano 
This study seeks to evaluate types and time trends for treatment of            
fistula-in-ano 
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AIMS AND OBJECTIVES 
A Prospective and Retrospective analysis of Fistula in ano to identify  
1. Incidence in Male, Female 
2. Etiology 
3. Symptoms  
4. Various Surgical Techniques  
5. Complications 
6. Follow up 
Need of the study 
 Fistula in Ano develops in 26-38% following Anal Abscess 
 The incidence in men 12.3/100000 population 
 The incidence in women 5.6/100000 population 
 Faecal incontinence, recurrence, discharge-common. Symptoms 
generally affect quality of life significantly So proper surgical 
technique is mandatory. 
 Surgery is the treatment option with the goals of draining infection, 
eradicating the fistulous tract, and avoiding persistent or recurrent 
disease while preserving anal sphincter function. 
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Aims of the study 
 A retrospective and prospective analysis of various surgical 
treatment modalities in PSG Hospital on Fistula-in-ano 
 To analyze the morbidity in patients fulfilling the 
Inclusion/Exclusion criteria, from admission till 6 months post-
operatively. 
 To review the pathophysiology of anal fistula 
 To review both simple and complex fistulas and treatment options 
 To compare and analyse the efficacy and outcomes of all surgical 
treatment options 
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REVIEW OF LITERATURE 
Fistula in ano is one of the earliest known affliction of mankind as evident 
by its existence which was mentioned in early biblical literature. The 
treatment of fistula in ano described as early as 220BC.  
Hippocrates: 
The treatment of fistula in ano was described by Hippocrates in 450BC and 
described in latin as “liber de fistulis”. He describes clearly the relation 
between anorectal abscess and fistula. He describes cutting open of the 
abscess before it suppurates and burst into rectum. Some of the technique 
used today were already described by Hippocrates before like examining 
the depth of fistula by probing it. He described the use of cutting seton 
method. He used a horsehair wrapped around a lint thread which was 
advanced through the fistula with a tin guide (the „specillium‟). The ends 
of the seton were then tied around the enclosed sphincter tissue and 
tightened until fistula tissue become crushed and putrified. It formed the 
origin of seton technique.   
Celsus described the use of setons for treatment of fistula. Fistula in Ano 
develops 26-38% following anal abscess. Incidence in men is 12.3/100,000 
population and in women is 5.6/100,000 population. Male to female ratio 
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is 1.8:1.fistula in latin means reed or pipe. Goligher define fistula as 
chronic granulating track connecting two epithelial lined surface. 
Medicated setons were used much earlier by Sushrutha. 
 
 
 
 
 
 
The  Kshar-sutra was first mentioned by the "Father of 
Surgery" Sushruta in the book “ SUSHRUT – SAMHITA” for the 
treatment of Bhagandara (fistula- in - ano), Nadi Vrana (sinus), Arsha 
(Piles), Arbuda (Excision of small benign tumour) etc. Kshar-sutra 
procedure is one of the most effective para-surgical procedure of 
Ayurveda. This technique of Ayurveda provides a safe , economical, given 
100% result to the variety of all Ano-rectal diseases like Anal 
Fistula(bhagander), Piles(arsha), Chronic Anal Fissure (Parikartika), Pilo-
nidal sinus (nadivrana), Rectal Polyp, Anal Condyloma etc. 
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-The Ksharsutra means KSHAR + SUTRA 
-KSHAR means Alkaline Ayurvedic Medicine 
-SUTRA means Thread 
It is a  medicated  thread prepared by 21 coatings of different medicines. 
 11 coating of SNUHI-KSHEER (latex of Euphorbia Nerrifolia – use as 
binding agent and having cutting property,) 7 coating of KSHAR (The 
kshar powder obtained by the burning of various herbs acts as anti 
microbal action & Cutting properly. 3 coating of Haridra (Turmeric 
powder) use for healing 
 The mechanical action of the thread and the chemical action of the drugs 
coated , collectively do the work of cutting, curetting, draining, and 
cleaning the Ano-rectal diseases, Thus promoting healing of the wound. 
This also acts both as the antiseptic and fibrotic agent to induce the 
healing. The process of healing starts from deeper tissues & travels 
towards periphery. 
Benefits of the ksharsutra 
 
a) The Ksharsutra procedure is performed mostly under Local 
anaesthesia. 
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b) The procedure does not require hospitalization for more than 6 to 8 
hours or 1 day. 
 
c) The patient requires minimal bed rest & can resume his / her daily 
routine within 1 to 2 days. 
 
d) It gives freedom from painful dressings. 
 
e) The drugs coated on the Kshar-Sutra are slowly and gradually 
released into the track and the wound, leaving no pockets overseen. 
These pockets are drained out by the action of the drugs. 
 
In this process there is no need of dressing , High Anti-Biotic medicine, 
I / V Fluid & blood transfusion. 
 
f) This therapy successful even when Haemoglobin of patient 3.8 
gm/dl %. (Ref:1-4) 
John of Arderne  
John Ardene (1307-1390), English surgeon described in early 14th century, 
the principles and surgical technique used for fistula. He was the first to 
describe and to use lay open method for treatment of fistula.  he wrote the 
book – “Treatises of Fistula in Ano, Haemorrhoids and Clysters”. In this 
book, he described the treatment for fistula in ano. 
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The patient was placed in a lithotomy position. Four threads were taken 
through the fistula tract and ends drawn out through the anus.  Threads 
were knotted to stop bleeding. Grooved instrument was pushed inside 
through the fistula into rectum, where it made contact with another  
instrument. Intervening segment was removed by him. Bleeding between 
the ligatures was stopped with a hot sponge. He pioneered in 
demonstrating the fistula surgical techniques. (Ref:5) 
King Louis xiv and Charles-Francois Felix de Tassy 
Louis xiv developed perianal abscess in 1686. The abscess was lanced but 
it recurred within 3 months. Surgeon Charles Francois operated him after 
reading all ancient and contemporary literature about fistula in ano. He 
developed an instrument “le bistouri a la royale”. He operated on the king 
and Louis xiv recovered from fistula with in a 
month.  
 Park in 1961 demonstrated infected 
analglands and paved way for 
pathophysiology. Setons  used in the 
treatment of high trans sphincteric and 
anterior sphincteric fistula in ano. Materials 
used as setons include prolene, silastic catheter, vessel loops, rubber 
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bands,vessel loops etc. Two types of setons include cutting which incise 
the tissue and non cutting that facilitate drainage of tract. Amedicated 
ayurveda thread called “kshar sutra” described by sushrutha, a linen 
thread soaked in kshar which is a plant extract that has a tissue cutting 
property. It takes 3 weeks to 1 year to cut through the tissue. Non cutting 
setons were used in chronic sepsis and chronic diseases like HIV positive 
cases. Use of seton can be used in staging procedure in combination with 
fistulotomy. Study done between seton technique and fistulectomy with 63 
members. 56 males and 7 females. Mean age group 38.4 years. 31 belong 
to fistulectomy and 32 in seton group. Mean healing rate is same in both 
group. But recurrence was about 8% in seton technique,compared to none 
in fistulectomy group. Incontinence not seen in both groups. (Ref:6) 
Charles Dickens and Sir Frederic Salmon 
In early times, not only the kings suffer of perianal fistula. Charles Dickens 
(1812-1870) also had a perianal fistula. He was operated by Sir Frederic 
Salmon on 8th October 1841. In a letter to his friend, he described the 
procedure as …”last Friday morning, (I)was obliged to submit to a cruel 
operation and cutting out root and branch of the disease caused by 
working over much, which has been gathering it seems for many years. 
The operation was successful, hence Dickens felt gratitude to Frederic, 
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hence he persuaded Lord Iveagh (empire) to start a dispensary for the poor, 
afflicted with fistula,piles and other diseases of rectum and lower intestine, 
which was to become the well known St. Marks Hospital, in London. 
Salmon attributed Dicken‟s fistula to “the consequence of too much 
sitting”. Perianal fistulas are common now adays in persons who are doing 
specific occupations like tailors. 
 Fredrick salmon described in 1835, 129 cases operated for fistula and 
followed up for 5 years. (Ref:7) 
Sir Hugh Lockhart – Mummery’s opinion 
In early 20th century, renowned surgeon Hugh Lockhart – Mummery 
expressed the frustration that many surgeon‟s encounter in treating 
perianal fistulas. He described as “probably more surgical reputations 
have been damaged by the unsuccessful treatment of fistula than by the 
excision of the rectum or gastroenterostomy. Several years later he stated – 
“the bad results of laparotomy are generally buried with flowers,while the 
fistulae go about the world exhibiting the unsuccessful results of the 
treatment”  
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Fistulotomy is the standard treatment for low simple anal fistula, 
submucosal and low intersphincteric fistula. It is usually used as a single 
staged procedure but can be used as in complex staged procedure with 
fistulotomy. Fibrin glue is a mixture of fibrinogen, thrombin and calcium 
ions which when combined form a soluble clot due to cleavage of 
fibrinogen to fibrin. This clot seals the fistula tract in 30- 60 seconds. 
Between days 7 and 14 the tract is replaced by synthesized collagen. The 
reasons for failure caused by inadequate removal of granulation tissue and 
abscess formation due to lack of complete tract filling with glue.The 
advantages of this procedure are that it is a simple procedure without any 
learning curve. There is no decrease in incontinence level. Fibrin plug is 
introduced in 2006 by Robb & colleagues. The plug is made up of 
lypophilized porcine small intestinal submucosa shaped in a conical 
fashion which increases the mechanical stability thus avoiding 
dislodgement during straining. The reasons for failure of the plug are 
improper securing of the plug to the primary opening leading to 
dislodgement. (Ref:8-9) 
Fistulotomy is usually done for simple fistula and its the most common 
procedure done now throughout the world. Healing is better and recurrence 
is same as with fistulectomy. Its technically easier compared to 
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fistulectomy. Fistulectomy involves more damage to sphincters when 
compared to fistulotomy. Fistulotomy  procedure is laying open of fistula 
tract and allow to healing by its own. But fistulectomy involves removing 
entire fistulous tract including secondary tracts. Disadvantages being 
sphincter injury. Faecal incontinence usually common in fistulectomy 
procedure. Fistula will present as acute abscess or as discharging  sinus 
that my cause skin irritation in the perineal region and affects the skin. 
Induration maybe felt subcutaneously. On doing  per rectal examination a 
nodule can be palpable in the anal canal wall. Primary opening  is 
identified and probe is introduced through the external opening  gently and 
probing is done the Goodsall rule, we can identify the anatomy of fistula. 
If the internal opening is difficult to identify, then techniques like probing 
the external opening, usage of methylene blue or hydrogen peroxide is 
used and planned for definitive procedure. It involves drainage of primary 
intersphincteric infection, delineate primary track across external sphincter 
and secondary tracks. But seton placement is preferred when there is 
presence of  anterior fistula and if involves 25 to 50% bulk of sphincter 
muscles. Close followup , proper post operative care is necessary for 
proper healing process. Sitz bath and regular dressing mandatory for 
healing the wound from depth to perianal surface 
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Multiple fistula tracts have been associated with higher failure rates.   
1. Adipose derived stem cells used in treatment of complex anal fistula.  
On comparision with fibrin glue, the results include recurrence rate of 17% 
at one year followup. (Ref:10) 
2.Mucosal Advancement  Flap is a sphincter sparing procedure where 
endorectal/ endoanal flaps are advanced to close the internal ring with or 
without closure of the tract. Healing rate varies from 77-100%. Recurrence 
rate was noted to be 23%.(Ref:11) 
3. Van Koperen and colleagues used the setons to drain the tracts followed 
by flap advancement with good results. Combining fibrin glue in 
conjugation with advancement flap in a study conducted by Ellis and 
Clarke. (Ref:12) 
4. LIFT procedure is ligation of the inter sphincteric fistula tract . This 
procedure is based on secure closure of the internal opening and removal 
of infected cryptoglandular tissue through the intersphincteric 
approach.The procedure was developed by Thai colorectal surgeon, Arun 
Rojanasakul, Colorectal Division Department of Surgery, Chulalongkorn 
University, in Bangkok, Thailand. in 2007. The first report of preliminary 
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healing result from the procedure were 94% in 2007.It included 18 pts with 
recurrence rate of 5.6%. Two major differences between LIFT and 
previously described techniques – ligation of fistulous tract is more secure 
and removal of infected glandular tissue by curettage is less time 
consuming and more practical. Bleier done both retrospective and 
prospective study that included 39 patients, 51.3% of whom were male. 
Mean age of the study group was 49 years. The average follow-up period 
was 24 wk. The success rate was 57%. Incontinence was 0%. This was the 
first study conducted in United states. Shanwani conducted a prospective 
study that included 45 patients out of which 71% were male. He continued 
study for 9 months. The success rate was 82.2% and recurrence rate was 
17.8%, mean average period of recurrence was 6 months. Healing time 
was 7 weeks. fecal incontinence was nil in his study. (Ref:13) 
Surgical techniques of LIFT Procedures 
 Identifing the internal opening 
 Incision at the intersphincteric groove 
 Dissection through intersphincteric plane and identify 
intersphincteric fistula tract 
 Secure  ligation of intersphincteric fistula tract 
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 Remove the fistula tract 
 Curette fistula tract from external opening 
5. Ellis introduced  BioLIFT procedure , using bioprosthetic graft derived 
from submucosa of porcine small intestine. BioLIFT technique is a 
variation of the LIFT technique in which a bioprosthetic is kept in the 
intersphincteric plane which helps in reinforcing the closure of the 
fistulous tract. The bioprosthetic graft acts as a physical barrier in the 
intersphincteric plane and facilitates healing process. The technique 
utilizes transection of the intersphincteric tract and closure of the fistula 
opening in the internal sphincter, which is similar to the procedure 
described by Matos, instead of ligating the intersphincteric tract. When 
compared to the LIFT, this technique has two potential disadvantages. 
First, it requires  extensive dissection in the intersphincteric space because 
the bioprosthetic graft must overlap the closure of the fistula tract by at 
least 1 to 2 cm in all dimensions. The second disadvantage is  relatively 
high cost of the bioprosthetic materials, which makes its usage less. 
Ellis did a prospective study on 31 patients .success rate was 94%  and 
recurrence was 2%.Mushaya did a randomized control study between LIFT 
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and ERAF(Endorectal Advancement Flap) and found to have similar 
success rates. (Ref:14) 
6.Han introduced LIFT – PLUG procedure by introducing bioprosthetic 
anal plug in fistulous tract. He done study in 21 persons and followed for 
14 months and found success rate of 95%Lehmann did LIFT study for 
recurrent fistula exclusively among 17pts and found to have healing rate of 
76% when followed up for 13.5 mnths. (Ref:15) 
7.Srikurnpiboon compared LIFT PLUS (LIFT WITH PARTIAL 
FISTULOTOMY). Technique and did a prospective study among 41 pts. 
Healing rate was found to be 83% and there was no incontinence.                
(Ref:16) 
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LIFT PROCEDURE 
      A.  Internal opening identification 
 
                               B. Incision made at intersphincteric groove 
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C.Identification of intersphincteric fistula tract 
 
D.Secure ligation of Intersphincteric tract 
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E.Curetting out through External opening 
 
F.Suture closure of the sphincter Muscle 
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8.VAAFT(Video Assisted Anal Fistula Treatment)  
VAAFT technique is used for treatment of  complex fistulas and their 
recurrences. (Ref:17). it involves two phases that includes both diagnostic 
and operative phases. It involves visualisation and localisation of internal 
fistula, fistula treatment from inside and internal opening closure. 
Avoidance of surgical wounds in the perianal region and faecal 
incontinence is less compared to other procedures because sphincter 
damages are avoided 
The technique involves a Fistuloscope, which energy source usually a 
unipolar cautery which is connected to a high frequency unit,  fistula brush 
and forceps attached to it. A semicircular or linear stapler also attached to 
it. 0.5 ml of synthetic cyanoacrylate which is placed in tiny catheter 
attached to fistuloscope. 
The fistuloscope has an optical channel, a working channel and an 
irrigation channel. Average working  length of about 18cm and  effective 
manipulation occurs around 14cm from target site. 
 
 
                    
 
 
     FISTULOSCOPE IN VAAFT PROCEDURE 
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VAAFT TECHNIQUE 
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The patient positioned in  the lithotomy position. Under spinal anaesthesia, 
The fistuloscope is introduced to the fistulous opening and optimal 
solution (5000 cc glycine and mannitol 1% solution) is used. 
TECHNIQUE OF VAAFT: 
1. The diagnostic phase 
2. The operative phase 
1) THE DIAGNOSTIC PHASE 
The diagnostic phase is used in correct localisation of the internal fistula 
opening. The fistuloscope is entered via the external fistula opening and 
space is created with washing solution (glycine 1% and mannitol 1%) . it 
opens the entire fistulous tract including the secondary tract. If the tract is 
blocked. The tissue which is blocking is removed using  2 mm forceps to 
facilitate the insertion of the fistuloscope. The direction of the telescope is 
positioned by the location of obturator and directed according to it. The 
movements include both slow left-right and up-down movements. The 
fistuloscope is guided according to transanally placed finger and reached 
upto the opening under spinal anaesthesia. The continous flow of  glycine-
mannitol solution facilitates identification of the internal opening. 
Analcanal  is retracted and internal opening is identified by the presence of      
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light of the telescope which is visualised in the rectum or anal canal. Thus 
the internal opening is clearly identified. When the opening is reached,  the 
rectal mucosa can be visualised on the screen. If the  internal opening is 
narrowed or if it is not viewed properly, then the rectal mucosa behind the 
light of fistuloscope is marked and suture stitches taken opposite direction 
of the internal opening and used as a guide and to perform the procedure. 
Then fistula is operated from within and started from internal opening to 
exterior aspect. 
2) THE OPERATIVE PHASE 
The entire fistula is destroyed from inside using fistuloscope.  Fistulous 
opening is closed and entire tract is destroyed from inside. The fistula 
canal is washed and waste debri is removed and the internal opening of 
fistula is closed completely and then fistula is destroyed . The procedure is 
carried out  under vision using a unipolar electrode which is introduced 
with the help of  the operative channel of the fistuloscope and is connected 
to the electrosurgical power source. The procedure is started by 
coagulating all fragments of the whitish material from the fistulous tract 
which is adherent to the fistula wall and all granulation tissue removed 
from the path. The movement is usually from inside to outside in a slow, 
steady manner and necrotic material removed completely. The process is 
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facilitated by using fistula brush. Entire debri removed.remove the 
fistuloscope. The internal opening is lifted using forceps about 2cm and 
stapler is inserted through the base. Then mechanical cutting and suturing 
done using stapler. Hermetic closure of the internal fistula opening can  be 
accomplished using a linear stapler. when semicircular stapler is used, the 
suture will be horizontal. If the linear stapler is used, the suture will be 
vertical. Cutaneous mucosal flap is raised if the internal opening is rigid 
and sclerotic and the passage of stapler is difficult. Hence fistulous tract 
removed completely. The procedure involves high expertise to do the 
procedure. Then synthetic cyanoacrylate is instilled inside to reinforce 
suture. Entire procedure is carried under vision. Fistulous opening is open 
to allow the secretions to drain completely. 
The benefits of the procedure includes  a perfect excision and a hermetic 
closure of the internal fistula opening. Secure closure is maintained to 
prevent  the risk of stool passage. Due to the tangential placement of 
sphincter, postoperative pain is reduced very much and it also facilitates 
healing easily.  
The advantages of the VAAFT technique includes  no surgical wounds in 
the buttocks or perianal region, perfect localisation of the internal opening 
is possible under direct vision and removal of fistula completely from the 
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inside. There is no need to classify the fistula as trans sphincteric, 
extrasphincteric or high anal fistula, as the procedure is carried out from 
inside and no damage is caused to the sphincters. There is reduced risk of 
post operative faecal incontinence, pain, no medications and resuming 
work easily. 
9. EXPANDED ADIPOSE-DERIVED STEM CELLS (ASCs) 
Mesenchymal adult stem cells derived from adipose tissue, can be 
differentiated into various types of cell. First described by Garcia-Olmo.  
Adipose tissue is used as the source of stem cells because of two biological  
properties:. the ability of the tissue to suppress inflammation and the grade 
of differentiation potential.  Fat tissues are obtained by procedures like 
liposuction, and the fat cells derived can be harvested without  adverse 
effects on the patient. Adipose-derived stem cells are safe for the treatment 
of a fistula in diseases like Crohn‟s and also used in the treatment of 
complex anal fistulae. Randomised control trials were conducted and they 
proved ASC more beneficial when compared to fibrin plug. The treatment 
using ASC involves: 1) identification of tract and its internal opening;  2) 
curetting the fistulous tract, lying on the intersphincteric plane; 3) closing 
the internal opening of the fistulous tract; 4) injecting  cell suspension into 
the fistulous opening through a long fine needle and identifying entire 
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course; 5) followed by sealing the tract with fibrin glue. Studies conducted 
revealed healing rate is better when  treated with ASC and fibrin glue, 
rather using fibrin plug alone. ( P < 0.001).  Studies further revealed 
healing rate was similar between the Crohn's and the non-Crohn's patients 
who underwent the procedure. 
An advantage of using adipose derived stem cells for treating anal fistula is  
no resection of the tract and no involvement of anal sphincter. The 
limitations of using ASCs-based therapy includes the cost of treatment 
which is very high compared to other procedures. Secondly, technique 
involves  secure closure of the internal opening and  injection of the cell 
suspension over the tract completely involves  technical difficulty. It limits 
the usage of ASC from extensive usage. 
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FISTULA IN ANO  
30 
 
ANORECTAL ANATOMY AND PHYSIOLOGY 
Anal canal extends from anus to rectal ampulla and it is 2-5cms in length, 
shorter in women than in men. Its lower part is lined by stratified 
squamous epithelium. The dentate or pectinate line is situated in the 
middle of the canal and is defined by anal valves. The anal glands open 
into the crypts above the valves and can be situated in the submucosa and 
reach through the internal sphincter into intersphincteric space. At the 
dentate line, epithelium becomes transitional. The anal transitional zone 
with modified columnar epithelium has a high sensory innervations and 
play a role in continence and normal defaecation. 
The anal canal lined by sphincter muscles. The smooth internal sphincter 
consist of thickened circular muscle layer of the bowel wall. The circular 
external sphincter merges with puborectalis above, which forms a sling 
behind uppermost part of analcanal and attaches forward to pubic bones. 
The puborectalis is the lowermost part of funnel shaped levator ani 
muscles, which separate perineum from pelvic cavity 
Anal continence depends on several mechanisms. The internal sphincter is 
estimated to contribute 52 to 85% of the resting pressure in the high 
pressure zone of anal canal (GORDON & NIVATVONGS – 1999). The 
external sphincter is unique compared to other striated muscle as it has 
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continuous tonic activity even at rest. The basal tone varies with postural 
changes and activity increases with increased abdominal pressure and 
rectal distension. (Ref:18-20) 
CLASSIFICATION OF FISTULA IN ANO. 
 Classification of fistula in ano is based on the anatomy of the course 
of the fistulous tract which is based on relation to the analsphincter 
complex. Milligan & Morgan in 1934 classified the fistulas 
into high fistulas-those in which the internal opening lies above the 
anorectal ring and low fistulas-those in which the internal opening 
lies below the anorectal ring. 
 Low level fistula includes subcutaneous type,submucosal type and 
low anal type.  
 High level fistula includes high anal type and pelvirectal type. 
 Park classified the fistulas into sub-mucosal, intersphincteric, supra-
sphincteric and extra-sphincteric. 
 The submucosal fistula is not involving any sphincter and is 
simplest to manage. 
 Intersphincteric fistula traverses through the internal 
sphincter which constitutes about 70% of all anal fistula  
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 Trans sphincteric fistulas pass through both the internal and external 
sphincters and are further subdivided into low and high depending 
on the part of the external sphincter muscle. The low fistulas involve 
only the outer part of the external sphincter while high fistulas 
involve greater part of the external sphincter.  It constitutes about 
25% of all anal fistula 
 Supra sphincteric fistula typically arise at the dentate line internally, 
cross above the internal sphincter but below the puborectalis and 
exit on to the peritoneal site. 
 Extra sphincteric fistula are rare and do not involve the sphincter 
complex. They arise from above the denatate line into the ischio-
rectal fossa. These are non cryptogenic in nature.  
 The drawback of this classification is need for classification oriented 
investigations in form of transrectal ultrasound or Magnetic 
resonance imaging of perineum. 
Fistula is now classified as 
1) subcutaneous 
2) sub muscular (intersphincteric, low transsphincteric) 
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3)1complex,recurrent(hightranssphincteric, 
suprasphincteric,extrasphincteric,multiple tracts,recurrent) 
4)  second stage 
Unlike the present coding, park‟s system doesn‟t include subcutaneous 
fistula. These fistulas are not of cryptoglandular in origin but are usually 
caused by unhealed anal fissures or anorectal procedures, such as 
hemorrhoidectomy or sphincterotomy (Ref:21-22)s 
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PATHOPHYSIOLOGY  
 Cryptoglandular theory is the accepted theory. Fistula in ano 
develops from infected glandular tissue. It results in perianal abscess and 
fistula formation. of the perineal sepsis and anal fistulas.  
The obstruction of anal crypt gland with internal debris leads to 
infection in these glands,which penetrate, into the anal complex and it 
causes abscess formation.Abscess collects in anatomical spaces where the 
anal gland terminates and it transverse to the perineal spaces.  
 Anorectal abscess is an acute manifestation of the crypto-glandular 
infection and fistula is a chronic sequelae of this infection. Almost one 
third of the patients who undergo drainage of the Anorectal abscess 
develop the anal fistula. In  recurrent perineal abscess, presence of anal 
fistula should be investigated and treated accordingly. 
 In 10%of the patients, causes include inflammatory bowel 
disease,fungal infection, tubercular infection, neoplasm or trauma. 
Complex fistula requires a staged procedure for the management. (Ref:23-
24) 
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PHYSICAL EXAMINATION AND IMAGING STUDIES: 
No specific lab investigations required for fistula in ano. Diagnosis 
mainly based on physical examination. Examiner should observe entire 
perineum, should look for external opening which appears as a sinus or 
elevation of granulation tissue. spontaneous discharge of pus or blood via 
external opening may be seen. 
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GOODSALL’S  RULE: 
Early in the 20th century, Goodsall proposed  a tendency in relationship 
between the location of external and internal openings of perianal  
fistulas.  
 
 
 
1) if the external opening is located posterior aspect,the fistula originates 
from dorsal midline  
2) if the external opening is anterior,it probably runs directly into nearest 
crypt. If the distance to the anal verge is more than 3 cms,(on either side of 
the tract),the tract is likely to run in a curved tract to the posterior 
commissure. 
This is commonly known as Goodsall‟s rule. 
Prospective study conducted by Cirocco and Reilly in 216 patients in 
perianal fistula of cryptoglandular origin. Goodsall‟s rule found to be 
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accurate in only 50% of patients. So reliability of this rule is still been in 
controversy. (Ref:25-26) 
Digital rectal examination: 
It  reveals a fibrous tract or cord beneath the skin. lateral or posterior 
induration suggests deep postanal or ischiorectal extension 
We should look for sphincter tone,relationship between fistulous tract and 
anorectal ring. It provides an indication of the quality of sphincter 
complex, by assessing sphincter tone. 
Eckhardt and co workers have shown sensitivity and specificity in 
assessing anal sphincter competence in only 63 and 57% of people. 
 Anoscopy required to identify internal opening. Proctoscopy is indicated 
in presence of rectal diseases such as crohn‟s or associated conditions. 
Probing: 
Route of perianal fistula can be identified by introducing a probe into the 
external opening. But now probing is not usually done . Risk of developing 
a false passage is high in case of probing.  
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Injection of methylene blue: 
Preoperative injection of diluted solution of methylene blue into the 
external opening helps in localizing the internal opening. It may results in 
staining of tissues. 
Injection of hydrogen peroxide is seems to be a good alternative for 
methylene blue. Hydrogen peroxide does not stain the operating field and 
can often be helpful in identifying internal anal opening.  
Imaging studies are not performed usually for routine fistula evaluation. 
Indicated in recurrent disease, multiple fistulas, difficulty to identify 
primary opening or secondary tracts 
Following imaging studies can be done : 
1) fistulography: 
Involves injection of iv contrast via the internal opening followed by 
anteroposterior,lateral and oblique radiographic images to outline course of 
tract.  
Until early ninetees, perioperative classification of fistula,mainly based on 
inspection, digital examination, probing and fistulography.  
40 
 
Reserved mainly for cases there is suspicion of communication between 
rectum and neighbouring organs 
False negative and false positive respectively noted about 64 and 8% of 
cases. Kujjpers done a retrospective study and showed prediction of 
internal opening via fistulography is only 28%. Ahlback and coworkers 
used special balloon catheter to demarcate upper and lower boundary of 
the canal. Using the catheter, they able to localize in only 72% of the 
patients. Weisman conducted a retrospective study in 27 patients and 
showed correct classification of fistula in about 89% of patients.                
(Ref:27-28) 
2) Endorectal USG: 
Passage of 7 or 10 MHz transducer into analcanal to help in defining 
muscular anatomy differentiating intersphincteric from transsphincteric 
type. Water filled transducer helps to evaluate rectal wall for 
suprasphincteric extension. Addition of hydrogen peroxide via the external 
opening helps to outline entire fistula course.  
Graf and Eberhard performed preoperative endoanal sonography in 35 
patients with perianal fistula and found to localize the internal opening in 
17 patients. Deen and colleagues able to classify perianal fistula in about 
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60%of people. In 1993, Cheong suggested the accuracy of preoperative 
classification  of perianal fistula using endosonography can be improved 
by using hydrogen peroxide. In a retrospective study including 37 patients, 
able to identify in about 92% of patients using hydrogen peroxide. 
Hydrogen peroxide causes passing sensation of patient, not burden to 
patients. It is not used in patients with closed external opening. But its 
usage has increase the accuracy of endosonography in detection of 
analfistulas.  
An extension or abscess was defined as a hypoechogenic structure 
distinguishable from primary tract  
The anatomy of the fistula described as 
1) presence of a primary tract-superficial,suprasphincteric,extrasphincteric 
and transsphincteric  
2) presence of internal opening- (Ref:31-34) 
3) MRI: 
MRI scans show 80-90% concordance with operative findings when 
primary tract course and secondary extensions observed. Investigation of 
choice for complex fistula and recurrent fistula. (Ref:35-36) 
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MRI clearly identifies sphincter complex, levator plate, and the 
ischiorectal fossae. It shows fistulous tracks, inflammation, and abscesses 
with regions of low to intermediate signal intensity, but it cant be 
distinguished from normal structures like sphincters and levator ani 
muscles. On T2-weighted and STIR images, clearly define pathologic 
processes like  fistulas, secondary fistulous tracks, and fluid collections 
from normal structures. It appears as areas of high signal intensity in 
contrast with the lower signal intensity of sphincters, muscles, and fat 
(especially on STIR images). STIR imaging has certain limitations in 
delineating structures. In some cases, STIR imaging failed to demonstrate 
secondary tracks, as it wont reveal small residual abscesses with 
edematous inflammatory change. MRI plays a vital role in finding 
complex fistulas. It helps in identifying all secondary tracks. In recurrent 
fistulas, MRI plays a major role in treating the patients.  
MRI grading of perianal fistulas: 
Grade 1: simple linear intersphincteric fistula 
Grade 2 : intersphincteric fistula with abscess or secondary tracks 
Grade 3 : trans sphincteric fistula 
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Grade 4 : trans sphincteric fistula with abscess or secondary tract within 
the ischiorectal fossa 
Grade 5 : supralevator and translevator disease 
If the ischioanal and ischiorectal fossae are not affected, then disease 
process is confined to sphincteric complex 
If there is presence of track or abscess in ischiorectal fossa, then it is 
confined to complex perianal fistula, usually grade 3 or 4 trans sphincteric 
fistula. If the track crosses levator plate, translevator fistula (grade 5) is 
present. Hence MRI acts as a diagnostic role in anal fistula. 
4) CT scan 
Used in perirectal inflammatory disease. Better in delineating fluid pockets 
that require drainage than for small fistulas (Ref:29) 
CT fistulogram plays an important role in diagnosis of perianal fistula. 
Preoperative period,  CT fistulography is used for the identification of the 
internal and external openings and latent ramifications,which cant be made 
out clinically. By 3D images, an internal opening which is in continuous  
with one or more external openings by the VR technique. Addition 
information regarding, latent ramifications can be  easily identified by CT 
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fistulogram by relative more images. Major disadvantage on using  CT 
fistulography is difficulty in identification of secondary ramification or  
primary tract which when obstructed with debris. Contrast material will 
not be filling the tract when filled with debri which makes it difficult to 
identify. Other disadvantage is that procedure depends on the existence  of 
an external opening.. If the internal opening is not identified or contrast is 
not filling the fistulous tract, then MRI is used for identification of fistula                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
5) Barium study 
Indicated only in multiple fistulas or recurrent disease – to rule out 
inflammatory bowel disease (Ref:30) 
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INSTRUMENTS 
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MATERIALS AND METHODS 
Type of Study : Retrospective & prospective study 
Period of study : Jan 2014 to June 2015 
Place of Study : PSG Hospitals, PSG IMS&R, Coimbatore, 
    Tamilnadu. 641004 
Sample Size : 75 Cases 
 This study had been approved by the Institutional Ethical 
Committee. 
Plan of Study : 
The detailed case history, clinical examination, Type of surgery, 
duration of stay, complication of the cases per recorded. 
The following factors were compared for newer and older surgical 
techniques  
- anaesthesia, technique and operative care 
- duration of surgery 
47 
 
- intra operative complications 
- post operative complications – pain, discharge, bleeding, fecal 
incontinence 
- length of hospital stay 
- cost effectiveness 
- postop readmission 
- recurrence 
 
INCLUSION CRITERIA 
- All types of fistula – both high and low 
- Both male and female patients 
 
EXCLUSION CRITERIA  
- Medical and surgical contraindications to spinal anaesthesia 
- Severe comorbidities 
- Superficial fistula 
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- Complex fistula due to the following causes 
a) inflammatory bowel disease 
b) previous radiation therapy 
c)  Tuberculosis 
d)  steroid 
e)  HIV 
f) Diverticulitis    
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OBSERVATION AND RESULTS 
In our study total 75 cases who underwent fistula surgery were taken 
Results were analysed according to  
1. age  
2. sex 
3. Type of Fistula 
4. Complaints 
5. Previous Surgery 
6. Interval between previous surgery and fistula  
7. Co morbidities 
8. Type of surgery 
9. Duration of Hospital stay 
10. Complications 
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Sex and Age Wise Classification 
    
PROBLEM 
Total simple complex 
SEX Male  48 12 60 
 64.0% 16.0% 80.0% 
Female  12 3 15 
 16.0% 4.0% 20.0% 
Total  60 15 75 
 Total 80.0% 20.0% 100.0% 
SEX
femaalemale
C
ou
nt
60
50
40
30
20
10
0
PROBLEM
simple
complex
 
About 80% of fistulas operated were simple. 20% - complex fistulas. 
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 Sex and Age Wise Classification 
    
AGE 
Total 16-20 21-30 31-40 41-50 51- 60 
SEX Male  1 8 16 23 12 60 
 1.3% 10.7% 21.3% 30.7% 16.0% 80.0% 
Female
 
 0 1 5 7 2 15 
 .0% 1.3% 6.7% 9.3% 2.7% 20.0% 
Total  1 9 21 30 14 75 
 1.3% 12.0% 28.0% 40.0% 18.7% 100.0% 
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In our study, 80% of patients were male and majority of patients were in 
age group  
Majority of  patients were in age group 30-50 years of age. 
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Sex and Procedure Cross tabulation 
 
  
  PROCEDURE Total 
  
  Fistulectomy Fistulotomy VAAFT LIFT SETON   
SEX           Male  30 20 5 3 2 60 
     40.0% 26.7% 6.7% 4.0% 2.7% 80.0% 
  female 
 
 
8 5 0 2 0 15 
     10.7% 6.7% .0% 2.7% .0% 20.0% 
              Total  38 25 5 5 2 75 
   
50.7% 33.3% 6.7% 6.7% 2.7% 
100.0
% 
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In order to test the significant difference among sample chi square test 
applied. For this hypothesis as mentioned below is developed. 
 Ho: There is no significant difference between male and female 
samples regarding procedure wise classification. 
 H1:  There is significant difference between male and female 
samples regarding procedure wise classification. 
From the output, Chi – square test value =   13.025 
 The P value is in this cases is .553 which is higher than the 0.05 (5 
percent level of significant). So there is much evidence to reject the null 
hypothesis at 5 percent level of significance. Therefore alternative 
hypothesis has been accepted. It seems that there is a significant difference 
between male and female sample regarding procedure wise classification 
are not equal. 
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33.30%
0
46.90%
5.30%
7.90%
2.60%
TYPES OF FISTULA
56 
 
ANALYSIS OF FISTULA IN ANO 
 
COMPLIANTS: 
 PAIN    - 76% 
           DISCHARGE   -  73.3%    
  FEVER   - 9.3% 
          ITCHING   - 17.3% 
          SWELLING   -  45.3% 
          CONSTIPATION  - 13.3% 
          BLEEDING   -  2.6% 
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PREVIOUS   SURGERY   FOR   PERIANAL   ABSCESS: 
 
       NO OF CASES        :     75 
       PERCENTAGE         :     53.3% 
 
 
 
32%
31%
4%
7%
19%
6%
1%
COMPLAINTS
PAIN DISCHARGE FEVER ITCHING SWELLING CONSTIPATION BLEEDING
58 
 
 COMORBID     CONDITION:      32% 
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HOSPITAL     STAY: 
          3 DAYS         :    14.6% 
          4-6DAYS      :     52% 
     ABOVE 6 DAYS :   33.3% 
 
 
 
 
3 DAYS
4-6 DAYS
> 6 DAYS
14.60%
52%
33.30%
DURATION OF HOSPITAL STAY
Series 1 Series 2 Series 3
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INTERVAL   BETWEEN   PREVIOUS    SURGERY     AND 
FISTULA FORMATION 
                                                                                      
    0 -6 MONTHS         :  25.3% 
               7MONTHS – 1 YEAR   :  12% 
               2 -3 YEAR                 :  5.3% 
               ABOVE 3YEARS        :  9.3 % 
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Level of Problem * Type of Treatment Cross tabulation 
 
 
  Type of Treatment Total 
Type Posterior Transphincteric Intersphincteric Recurrent Perianal 
Horse 
Shoe 
Shaped 
Multiple High Fistula Intermedia  
Simple 
1 13 11 3 24 2 3 1 2 60 
Complex 
2 1 1 2 7 1 1 0 0 15 
Total 
3 14 12 5 31 3 4 1 2 75 
 
In order to test the significant difference among sample chi square test 
applied. For this hypothesis as mentioned below is developed. 
 Ho: There is no significant difference between level of problems and 
types of treatment. 
 H1:  There is significant difference between level of problems and 
types of treatment. 
From the output, Chi – square test value =   3.379 
The P value is in this cases is .0852 which is higher than the 0.05 (5 
percent level of significant). So there is much evidence to reject  the null 
hypothesis at 5 percent level of significance. Therefore alternative  
hypothesis has been accepted. It seems that there is a significant difference 
between level of problems and types of treatment. 
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Type of Treatment * Investigation Crosstabulation 
 
Count  
  
Investigation 
Total MRI TRUS proctoscopy 
Type of 
Treatment 
Posterior 0 0 3 3 
Transphincteric 4 3 7 14 
Intersphincteric 9 3 0 12 
Recurrent 1 4 0 5 
Perianal 19 9 3 31 
Horse Shoe 
Shaped 2 1 0 3 
Multiple 3 0 1 4 
High Fistula 1 0 0 1 
Intermedia 1 1 0 2 
Total 40 21 14 75 
  
In order to test the significant difference among sample chi square test 
applied. For this hypothesis as mentioned below is developed. 
 Ho: There is no significant difference between types of treatment 
and investigation. 
 H1:  There is significant difference between types of treatment and 
investigation. 
From the output, Chi – square test value =   14.217 
 The P value is in this cases is .0361 which is less than the 0.05 (5 
percent level of significant). So there is much evidence to reject  the 
alternative hypothesis at 5 percent level of significance. Therefore null  
hypothesis has been accepted. It seems that there is  no significant 
difference between types of treatment and investigation
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DISCUSSION 
Fistula in ano is an abnormal communication lined by granulation 
issue between anal canal and skin. These originate from anal glands 
located at the subepithelial layer of anal canal. 
Milligon & Morgon classified fistula into high and low fistulas 
based on internal opening. 
Park classified into submuscosal, intersphincteric, suprasphincteric and 
extra sphincteric 
Various surgical Techniques include  
1. Fistulectomy 
2. Fistulotomy 
3. SETON 
4. LIFT 
5. VAAFT 
LIFT (Ligation of Intersphincteric Fistulous Tract) is a sphincter 
sparing surgery based on secure closure of internal opening and removal of 
infected granulation tissue. 
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VAAFT (Video Assisted Anal Fistula Technique) – Mainly introduced 
for complex Fistulas. It consists of diagnostic and operative phase. 
suprasphincteric fistula & high transsphincteric fistulas are safety treated 
by SETON Placement. 
About  75 cases of Fistula in Ano have been operated in our institution. 
Age & Sex 
In our study MALE are predominantly  affected – 80% of total 
cases. Fistula in Ano most commonly found  between 30-50 yrs of age. 
It constitutes totally of 68% .Occurrence  of  fistulas are more 
common in middle age group. 
Types of Fistula 
Fistula can be classified as simple and complex fistula. In our study 
about 80% are simple fistula that includes 64% operated in male, 16% in 
female. 
Complex fistulas constitute about 20% - male 16% female 4% 
Anal fistulas can be categorised either simple (or) complex. 
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A Simple anal fistula include low trans sphincteric and intersphincteric 
fistulas that cross the external sphincter. 
Fistulas are complex if primary tract includes high trans sphincteric fistulas 
with (or) without a high blind tract. Suprasphincteric, and extrasphincteric 
fistulas, horseshoe fistulas, multiple tracts, anterior lying. 
In our study intersphincteric fistula is most common It constitutes 46.6%. 
Here the fistulous track confined to intersphincteric plane. 
Trans sphincteric fistula – 33.3%  
Here the fistula connects the intersphincteric plane with ischiorectalfossa 
by perforating external sphincter. 
Horse shoe fistulas 
Incidence - 4% in our study. Here the fistulous tract goes from one 
ischiorectal fossa to contralateral one through posterior rectum. 
Fistula with multiple openings constitute 5.3% 
Anterior Fistula 2.6% 
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Clinical Features 
 Patients presented to OPD with following Symptoms – pain, 
discharge, swelling in perianal region, itching, bleeding PR, 
Constipation and fever. 
 Most common presentation is pain & discharge which constitute 
about 75% 
CO-MORBID CONDITONS 
 33% of patients had co-morbid conditions – Diabetes, hypertension, 
Decompensated liver disease. 
Diabetes -  36% 
Hypertension – 36% 
Cardiac disease – 16% 
Others – 12% 
Type of Procedure 
In our study fistulectomy was done in 50% of cases Fistulotomy in 33.3% 
cases. 
 VAAFT  - 6.7% 
 LIFT  - 6.7% 
 SETON - 2% 
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SETON TECHNIQUE 
 Seton Technique is done for 2 cases in my study. 
 Both cases had high intersphincteric fistula to previous surgery in 
both case. 
 One patient had diabetes, HTN and cirrhosis 
Advantage 
 No recurrence  
 Post operative hospital stay 5 days 
Disadvantage 
 Regular follow up needed seton tightening  
 Post  operative complications more  
 Wound healing comparatively less 
VAAFT 
 6.7% cases underwent VAAFT 
 Is done for to simple and 3 complex fistulas 
 Post operative recovery very good 
 Length of hospital stay 7 days 
 Patients compliance better 
 No recurrence  
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LIFT PROCEDURE 
 Done in 5 cases. (6.7%) 
 Mainly done for Intersphincteric fistula 
 Post operative period, patients had less pain & would healing better 
 Mean period of stay 5 days 
 One patient had recurrence after 1 month which was managed by 
Fistulectomy 
Post operative period 
 Mean period of stay 3-5 days 
 All  patients treated with antibiotics, analgesics, symptomatic 
measure 
 Pain is the Major complaint in our study 
Recurrence 
 Found in 5 cases (7%) 
 Recurrence followed – Fistulectomy – 2 cases, Fistulotomy – 2 
cases, Lift procedure – 1 case 
 Mean average period between previous surgery and percent 
condition is 5 to 6 months 
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 Mean period of recurrence 3 months 
 3 patients had associated co-morbid condition – hypertension, liver 
disease & Diabetes 
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CONCLUSION 
1. Incidence of Fistula in Ano is more common in men - 80% 
2. Age Group – Most common between 30-50 yrs Constitutes about  - 
68% 
3. In our study simple fistulas are 80% , complex fistulas 20%. Most 
common type of fistula belongs to intersphincteric type  
4. Commonest presenting symptom  in our patients is pain & discharge 
5. Fistulectomy is the comment surgery performed  
6. About 33% of patients has comorbidities – mostly associated with 
Hypertension and diabetes 
7. Newer techniques like LIFT, VAAFT were also performed in our 
institution 
8. Mean period of stay in our hospital is 3-5 days 
9. All the patients are periodically followed up. 1 week, 1 month, 
3months & 6 Months 
10. 7% of patients had recurrence.  Mean period of recurrence  - 3 
months. Recurrent cases were associated with comorbidities  
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ANNEXURE – 1 : PROFORMA 
 
1. NAME                                                        OP  NO        /  IP NO: 
2. AGE/SEX 
3. ADDRESS 
4. DOA:                      DOS:                         DOD: 
5. COMPLAINTS AND DURATION 
Pain 
Discharge 
Fever 
Itching 
Swelling 
Constipation 
 
6. PREVIOUS SURGERY FOR PERIANAL ABSCESS/ 
FISTULA 
7. INTERVAL BETWEEN PREVIOUS SURGERY AND 
PRESENT CONDITION 
8. COMORBID CONDITION 
EXAMINATION 
1. GENERAL EXAMINATION 
 
2. LOCAL EXAMINATION: 
I. SITE OF FISTULA 
II. EXTERNAL AND INTERNAL OPENING 
III. LENGTH OF FISTULOUS TRACT 
IV. DISCHARGE 
V. PERIANAL ABSCESS 
INVESTIGATIONS 
1. ROUTINE INVESTIGATIONS 
I. Hb, TC, DC, ESR, BLOOD SUGAR, UREA, 
CREATININE 
II. URINE ROUTINE 
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III. HIV/HBSAG 
IV. CXR/ECG 
 
2. SPECIAL INVESTIGATIONS 
I. PROCTOSCOPIC EXAMINATION 
II. USG 
III. MRI FISTULOGRAM 
 
TYPE OF FISTULA 
A. HIGH / LOWANAL FISTULA 
B.  SIMPLE/ COMPLEX ANAL FISTULA 
TYPE OF SURGERY 
 LIFT TECHNIQUE/VAAFT 
 FISTULOTOMY/FISTULECTOMY/SETON TECHNIQUE 
ANAESTHESIA 
INTRA OPERATIVE CARE 
OPERATIVE TIME 
INTRA OPERATIVE COMPLICATIONS 
POST OP ANALGESIC REQUIREMENT 
ANTIBIOTIC COVERAGE 
POST OP PERIOD 
 PAIN/DISCHARGE/BLEEDING 
 FAECAL INCONTINENCE 
   LENGTH OF STAY: 
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 POST OPERATIVE- FOLLOW UP 
DURATION – 1 week, 1 month, 6  months, 1 year 
COMPLICATIONS –  
 Discharge 
 Pain 
  faecal incontinence 
 Bleeding 
WOUND HEALING 
RESUMPTION OF ROUTINE ACTIVITIES 
READMISSION/RECURRENCE: 
MEAN PERIOD OF RECURRENCE 
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ANNEXURE – 2 : MASTER CHART 
index 
 
ip/op 
no 
 
high/low 
anal 
fistula 
 
simple/ 
complex 
 
other 
types 
 
type of 
surgery 
 
date of 
surgery 
 
stay in 
hospital 
 
intra/ 
postop 
complication
s 
 R
ec
ur
re
nc
e 
 
first 
postop 
visit 
 
subsequent 
postop 
visits 
 
investigatio
ns -
CT/MRI/ 
PROCTOS
COPY 
 
associated 
illness 
 
1 
 
O1309
2701/I
140153
69 
 
low 
 
simple 
 
intersphi
ncteric 
type 
 
fistulec
tomy 
 
6/6/201
4 
 
9 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
MRI 
 
nil 
 
2 
 
O1306
3871/I
130276
56 
 
low 
 
simple 
 
transsphi
ncteric 
type 
 
fistulot
omy 
 
13/9/20
14 
 
4 days 
 
no 
 
no 
 
wound 
healthy 
 
pain & 
swelling 
 
TRUS 
 - 
3 
013040
500/i13
029503 
 
low complex  
multiple 
ext 
opening 
 
fistulec
tomy 
 
02\10\2
013 
 
4 days 
 no no 
wound 
healthy 
 
no cpts 
 
proctoscopy 
 - 
4 
011029
012 
 
low complex  
multiple 
ext 
opening 
 
fistulec
tomy 
 
5/9/201
3 
 
4 days 
 no no 
wound 
healthy 
 
no cpts 
 
proctoscopy 
 
retroviral 
positive 
,HEP B, 
 
5 
O1401
6851 
 
low complex  
multiple 
ext 
opening 
 
fistulot
omy 
 
18/3/20
14 
 
7 days 
 no no 
wound 
healthy 
 
no cpts 
 
proctoscopy 
 
psoariasis 
 
6 
O1303
5457 
 
low 
simple,r
ecurrent 
 
recurrent 
fistula 
 
fistulot
omy 
 
26/4/20
14 
 
7 days 
 no no 
wound 
healthy 
 
no cpts 
 
proctoscopy 
 
- 
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7 
O1306
1549 
 
low simple  
intersphi
ncteric 
type 
 
fistulot
omy 
 
5/9/201
3 
 
4 days 
 no no 
wound 
healthy 
 
no cpts 
 
proctoscopy 
 
hep B 
 
8 
O1000
0664 
 
high complex  
horsesha
ped 
 
fistulot
omy 
with 
abscess 
drainag
e 
 
02\12\2
013 
 
10 days 
 no no 
wound 
healthy 
 
no cpts 
 
MRI/PROC
TOSCOPY/
USG 
 
- 
9 
O1308
3718 
 
low simple  
posterior 
perianal 
 
fistulec
tomy 
 
28/11/1
3 
 
7 days 
 no no 
wound 
healthy 
 
no cpts 
 
proctoscopy 
 
nil 
 
10 
O1403
5669 
 
low 
 
simple 
 
transsphi
ncteric 
type 
 
fistulot
omy 
with 
seton 
techniq
ue 
 
12\6\14 
 
6 days 
 no no 
incontin
ence+ 
 
flatus/stress 
incontinenc
e 
 
MRI/usg 
 
GERD 
 
11 
O1403
5596 
 
high 
 
simple 
 
intersphi
ncteric 
type 
 
seton + 
I&D 
 
6/6/201
4 
 
4 days 
 no no 
wound 
healthy 
 
no cpts 
 
MRI 
 - 
12 
O1309
1349 
 
low 
 
complex 
 
transsphi
ncteric 
type 
 
fistulec
tomy 
 
5/6/201
4 
 
7 days 
 no no 
wound 
healthy 
 
no cpts 
 
MRI 
 
MNG/reflu
x 
esophagitis 
 
13 
O1403
5817 
 
low 
 
simple 
 
intersphi
ncteric 
 
fistulot
omy 
 
31/5/14 
 
6 days 
 
no 
 
no 
follow 
 
wound 
healthy 
 
no cpts 
 
MRI 
 
DM/anaem
ia/hypothyr
oidism 
 
89 
 
14 
O0808
6367 
 
high 
 
simple 
 
intersphi
ncteric 
type 
 
seton 
 
9/5/201
4 
 
6 days 
 no no 
wound 
healthy 
 
no cpts 
 
MRI 
 
cirrhosis/D
M/PORTA
L HTN 
 
15 
O1403
0241 
 
low 
 
simple 
 
posterior 
midline 
 
fistulot
omy 
 
7\5\201
4 
 
5 days 
 no no 
wound 
healthy 
 
no cpts 
 
TRUS 
 
DM/HTN 
 
16 
O1302
1638 
 
low 
 
simple 
 
posterior 
midline 
 
fistulot
omy 
 
7\5\201
4 
 
5 days 
 no no 
wound 
healthy 
 
no cpts 
 
TRUS 
 - 
17 
O1402
6174 
 
low 
 
simple 
 
transsphi
ncteric 
type 
 
VAAF
T 
 
22/4/20
14 
 
7 days 
 no no 
tendern
ess+ 
 
tenderness
+ 
 
TRUS 
 
gastric 
ulcer 
 
18 
O1303
5981 
 
low 
 
simple 
 
intersphi
ncteric 
 
fistulec
tomy 
 
18/3/20
14 
 
6 days 
 no no 
wound 
healthy 
 
no cpts 
 
TRUS 
 - 
19 
O1306
8972 
 
low 
 
complex 
 
intermed
iate 
fistula 
 
fistulec
tomy 
 
5/2/201
4 
 
5 days 
 
no 
 
no 
 
faecal 
incontin
ence+ 
 
incontinenc
e during 
urge/cough 
 
TRUS 
 
DM/HTN/
CRF/CAD/
MYASTH
ENIA 
GRAVIS 
 
20 
O1402
9989 
 
low 
 
simple 
 
intersphi
ncteric 
 
VAAF
T 
 
9/5/201
4 
 
4 days 
 
no 
 
no 
 
wound 
healthy 
 
induration 
&discharge
+ 
 
proctoscopy 
 
hypothyroi
dism 
 
21 
O1402
7328 
 
high 
 
complex 
 
transsphi
ncteric 
type 
 
fistulec
tomy/s
eton 
 
8/5/201
4 
 
7 days 
 no no 
wound 
healthy 
 
wound 
healthy 
MRI 
 - 
22 O13070446 
low 
 
simple 
 
intersphi
ncteric 
fistulot
omy 
3\10\20
13 
3 days 
 
no 
 
no 
 
wound 
healthy 
no cpts 
 
proctoscopy 
 - 
90 
 
     
23 
O0906
7439 
 
low 
 
simple 
 
transsphi
ncteric 
type 
 
fistulec
tomy 
 
24/1/20
15 
 
3 days 
 no no 
wound 
healthy 
 
no cpts 
 
TRUS 
 - 
24 
O1403
8325 
 
low 
 
complex 
 
transsphi
ncteric 
type 
 
fistulot
omy 
 
13/6/20
14 
 
5 days 
 
no 
 
YES 
 
wound 
healthy 
 
recurrence
+ 
 
MRI 
 - 
25 
O1403
9212 
 
low 
 
simple 
 
intersphi
ncteric 
fistulot
omy 
 
17/6/20
14 
 
5 days 
 no no 
wound 
healthy 
 
induration+ 
 
proctoscopy 
 - 
26 
O1404
0317 
 
low complex  
intersphi
ncteric 
fistulot
omy 
 
17/6/20
14 
 
5 days 
 
no 
 
no 
 
wound 
healthy 
 
induration+ 
 
proctoscopy 
 - 
27 
O1302
0782 
 
low complex  
intersphi
ncteric 
 
fistulec
tomy 
 
4/7/201
4 
 
5 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
TRUS 
 - 
28 
O1409
4495 
 
low complex  
multiple 
ext 
opening 
 
VAAF
T 
 
20/7/20
14 
 
10 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
TRUS 
 DM 
29 
O1404
1180 
 
low simple 
intersphi
ncteric 
type 
 
fistulec
tomy 
 
21/7/20
14 
 
14 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
MRI 
 - 
30 
O1404
2059 
 
low simple intersphincteric 
fistulot
omy 
22/7/20
14 
 
14 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
TRUS 
  
31 
O1404
6377 
 
low complex  
horsesha
ped 
 
fistulot
omy 
22/7/20
14 
 
14 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
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32 
O1002
3237 
 
low simple intersphincteric 
fistulot
omy 
22/9/20
14 
 
5 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
MRI 
  
33 
O1406
7088 
 
low simple 
intersphi
ncteric 
type 
fistulec
tomy 
 
30/9/20
14 
 
5 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
TRUS 
  
34 
O1407
1483 
 
low simple 
intersphi
ncteric 
type 
fistulec
tomy 
 
29/10/2
014 
 
5 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
MRI 
  
35 
O1407
1507 
 
low simple intersphincteric 
fistulec
tomy 
 
31/10/2
014 
 
5 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
 
retroviral. 
 
36 
O1307
1515 
 
low simple intersphincteric 
fistulec
tomy 
 
6\10\20
13 
 
4 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
 
CAD 
 
37 
O1307
6426. 
 
low simple intersphincteric 
fistulec
tomy 
 
29/10/2
013 
 
6 days 
 
no 
 
no 
follow 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
  
38 
O1308
0496 
 
low simple 
intersphi
ncteric 
type 
fistulec
tomy 
 
16/11/2
013 
 
6 days 
 
no 
 
YES 
 
 
wound 
healthy 
 
perianal 
absces 
\fistula - 
I&D 
 
TRUS 
  
39 
O1308
2509 
 
low simple 
intersphi
ncteric 
type 
fistulec
tomy 
 
21/11/2
013 
 
3 days 
 
no 
 
no 
follow 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
 
sickle cell 
trait 
 
40 
O1305
0561 
 
low simple intersphincteric 
fistulot
omy 
 
5/8/201
3 
 
3 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
  
41 
O1305
2286 
 
low simple intersphincteric 
fistulec
tomy 
 
7/8/201
3 
 
4 days 
 
no 
 
no 
 
wound 
healthy 
 
residual 
lesion 
 
proctoscopy 
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42 
O1306
0417 
 
low simple intersphincteric 
fistulec
tomy 
 
23/8/20
13 
 
3 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
  
43 
O1306
1549 
 
low simple intersphincteric 
fistulot
omy 
 
5/9/201
3 
 
5 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
 
hepatitis B 
 
44 
O1307
9818 
 
low simple intersphincteric 
LIFT 
 
20/11/2
013 
 
4 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
  
45 
O0803
5873 
 
low simple 
recurrent 
fistula 
 
fistulec
tomy 
 
10\12\2
014 
 
4 days 
 
no 
 
YES 
 
 
wound 
healthy 
 
recurrence
+ 
 
proctoscopy 
  
46 
O0604
8549 
 
low simple intersphincteric 
fistulec
tomy 
 
30/12/2
014 
 
4 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
MRI 
  
47 
O1008
0843 
 
low simple intersphincteric 
fistulec
tomy 
 
3/1/201
5 
 
4 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
  
48 
O1404
2113 
 
low simple intersphincteric 
fistulec
tomy 
 
18/11/2
014 
 
7 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
 
HTN/DCL
D 
 
49 
O1305
8901 
 
low simple 
recurrent 
fistula 
 
LIFT 
 
6\11\20
13 
 
4 days 
 
no 
 
YES 
 
 
wound 
healthy 
 
recurrence
+ 
 
TRUS 
 
DM 
 
50 
O0902
9794 
 
low simple 
transsphi
ncteric 
type 
LIFT 
 
18/11/2
014 
 
4 days 
 
no 
 
YES 
 
 
wound 
healthy 
 
recurrence
+ 
 
MRI/TRUS 
 
hypothyroi
dism 
 
51 
O0600
9593 
 
low simple 
transsphi
ncteric 
type 
LIFT 
 
30/8/20
14 
 
5 days 
 
no 
 
no 
 
wound 
healthy 
 
recurrence
+ 
 
MRI 
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52 
O0504
3957 
 
low simple 
transsphi
ncteric 
type 
 
fistulec
tomy 
 
26/4/14 
 
12 days 
 
no 
 
YES 
 
 
wound 
healthy 
 
recurrence
+ 
 
TRUS 
 
nephrotic 
synd/CVA/
IHD 
 
53 
O1106
3274 
 
low simple 
intersphi
ncteric 
 
fistulec
tomy 
 
5/3/201
5 
 
4 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
TRUS 
  
54 
O1402
4554 
 
low simple 
transsphi
ncteric 
 
VAAF
T 
 
22/6/14 
 
7 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
TRUS 
 
Impaired 
glucose 
tolerance 
 
55 
O1501
3011 
 
low simple intersphincteric 
fistulec
tomy 
 
4/3/201
5 
 
4 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
  
56 
O1305
9061 
 
low simple 
intermed
iate 
fistula 
 
fistulec
tomy 
 
12\2\20
14 
 
5 days 
 
no 
 
YES 
 
 
wound 
healthy 
 
recurrence 
- I&D 
 
 
proctoscopy 
  
57 
O1400
2409 
 
low simple 
high 
fistula 
 
fistulec
tomy 
 
20/1/20
14 
 
5 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
 
Acid peptic 
disease 
 
58 
O1000
0664 
 
low simple 
recurrent 
perianal 
 
fistulec
tomy 
 
7/1/201
4 
 
5 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
  
59 
O1501
3180 
 
high 
 simple 
transsphi
ncteric 
 
fistulec
tomy 
 
7/3/201
5 
 
14 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
TRUS 
  
60 
O0906
7439 
 
low simple 
transsphi
ncteric 
recurrent 
 
fistulec
tomy 
 
24/1/20
15 
 
3 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
TRUS 
 
 
 
 
 
 
94 
 
61 
I14026
966 
 
low simple 
transsphi
ncteric 
 
 
LIFT 
 
23/9/20
14 
 
5 days 
 
no 
 
YES 
 
 
Dis 
charge 
 
recurrence 
 
MRI 
 
HTN 
 
62 
o14004
850 
 
low simple 
transsphi
ncteric 
 
fistulot
omy 
 
23/1/20
14 
 
4 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
  
63 
O1401
9183 
 
low simple 
transsphi
ncteric 
 
fistulot
omy 
 
18/3/20
14 
 
3 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
   
64 
O1307
7487 
 
low simple 
transsphi
ncteric 
 
fistulot
omy 
 
13/5/20
14 
 
3 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
  
65 
O1500
2461 
 
low simple 
transsphi
ncteric 
 
fistulot
omy 
 
21/1/20
15 
 
3 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
TRUS 
  
66 
O1008
0843 
 
low simple 
transsphi
ncteric 
 
 
fistulot
omy 
 
3/1/201
5 
 
4 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
  
67 
O1300
6167 
 
low simple posterior  
fistulot
omy 
 
18/3/20
15 
 
5 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
  
68 
O1502
3004 
 
low simple 
transsphi
ncteric 
 
 
fistulot
omy 
 
14/4/20
15 
 
7 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
TRUS 
  
69 
O1502
3363 
 
low simple 
transsphi
ncteric 
 
fistulot
omy 
 
16/4/20
15 
 
7 days 
 
persistent 
hypotension 
 
 
no 
 
wound 
healthy 
 
no cpts 
 
TRUS 
 
 
 
 
 
 
95 
 
70 
O1303
1743 
 
low simple 
horsesho
e,intersp
hincteric 
 
VAAF
T 
 
24/4/20
15 
 
8 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
MRI 
 
DM 
 
71 
O1206
2586 
 
low simple 
transsphi
ncteric 
 
fistulot
omy 
 
30/4/20
15 
 
5 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
TRUS 
  
72 
O1502
3384 
 
recurrent 
 simple 
transsphi
ncteric 
 
fistulot
omy 
 
21/4/20
15 
 
4 days 
 
no 
 
no 
 
wound 
healthy 
 
persistent 
pain/giddin
ess 
 
 
TRUS 
  
73 
O1502
8584 
 
low simple 
transsphi
ncteric 
 
fistulot
omy 
 
7/5/201
5 
 
4 days 
 
no 
 
no 
 
wound 
healthy 
 
no cpts 
 
proctoscopy 
  
74 O15029382 Low Simple 
intersphi
ncteric 
 
fistulec
tomy 
 
9/5/201
5 5days no no 
wound 
healthy 
 
no cpts 
 
proctoscopy 
  
75 O15029584 Low simple 
intersphi
ncteric 
 
fistulec
tomy 
 
10/5/20
15 4days no no 
wound 
healthy 
 
no cpts 
 
proctoscopy 
  
 
